5/6/2013 9:51:04 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
IRVINE, Calif., May 6, 2013 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer, announced today that it has entered into an agreement to issue securities in a private placement transaction to certain accredited investors that will result in proceeds to the Company totaling $2.4 million, to be received in two tranches, with the first tranche expected to close within two days and the second tranche to close following stockholder approval, subject to customary closing conditions.
Help employers find you! Check out all the jobs and post your resume.
comments powered by